Loopbaan van Daniela Oniciu
Eerdere bekende functies van Daniela Oniciu
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| OCUPHIRE PHARMA, INC. | Hoofd Techniek/Wetenschap/O&O | - | 31-12-2023 |
| NEUROBO PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-06-2014 | 01-11-2018 |
| ABIONYX PHARMA | Corporate Officer/Principal | 24-02-2010 | 01-02-2014 |
| PFIZER, INC. | Corporate Officer/Principal | 01-12-2004 | 01-02-2008 |
| ESPERION THERAPEUTICS, INC. | Corporate Officer/Principal | 01-02-2001 | 01-01-2004 |
| Creative Pharma Advisors LLC | Oprichter | - | - |
BioSavita, Inc.
 BioSavita, Inc. BiotechnologyHealth Technology BioSavita, Inc. operates as a biotechnology company, which develops a technology solution for the development of therapeutic antibodies. It focuses on developing a technology platform based on yeast (saccharomyces cerevisiae) expression systems that accelerate the discovery and development of antibody therapeutics and recombinant proteins. The company was founded by Nalini Ghag-Motwani in 1993 and is headquartered in Plymouth, MI. | Operationeel Directeur | - | - |
Opleiding van Daniela Oniciu
| Politehnica University of Bucharest | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 7 |
| Frankrijk | 2 |
| Roemenië | 2 |
Operationeel
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
| Chief Operating Officer | 1 |
Sectoraal
| Health Technology | 7 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| ABIONYX PHARMA | Health Technology |
| ESPERION THERAPEUTICS, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| OCUPHIRE PHARMA, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
BioSavita, Inc.
BioSavita, Inc. BiotechnologyHealth Technology BioSavita, Inc. operates as a biotechnology company, which develops a technology solution for the development of therapeutic antibodies. It focuses on developing a technology platform based on yeast (saccharomyces cerevisiae) expression systems that accelerate the discovery and development of antibody therapeutics and recombinant proteins. The company was founded by Nalini Ghag-Motwani in 1993 and is headquartered in Plymouth, MI. | Health Technology |
Gemphire Therapeutics, Inc.
 Gemphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Gemphire Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics of dyslipidemia, as well as non-alcoholic fatty liver disease. It offers a small molecule formulated as a tablet product under the Gemcabene brand. The company was founded by Charles L. Bisgaier and David Lowenschuss on October 30, 2014 and is headquartered in Livonia, MI. | Health Technology |
| Creative Pharma Advisors LLC |
- Beurs
- Insiders
- Daniela Oniciu
- Ervaring
